Buparlisib Hydrochloride (BKM120 HCl) is a specific and orally bioavailable pan-class I PI3K inhibitor that competitively inhibits PI3K/AKT kinase at the nanomolar level and suppresses cancer cell growth, making it suitable for studying breast cancer, glioblastoma, and solid tumours.
Molecular Weight:
446.85
Purity:
99.66%
CAS Number:
[1312445-63-8]
Formula:
C18H22ClF3N6O2
Target:
Apoptosis|||PI3K
T16365
T16365
* VAT and and shipping costs not included. Errors and price changes excepted